Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods

被引:18
作者
Li, Lu [1 ]
Gao, Qilong [1 ]
Xu, Guolin [2 ]
Shi, Bian [1 ]
Ma, Xuhui [1 ]
Liu, Huaimin [1 ]
Li, Qiujian [1 ]
Tian, Tongde [1 ]
Tang, Jingwen [1 ]
Niu, Hong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Integrated TCM & Western Med Dept, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Canc Hosp, Inpatient Dept, Zhengzhou, Henan, Peoples R China
关键词
Breast cancer; serum marker; prognosis; diagnostic threshold value; SVM; CA; 15-3; CEA; ASSOCIATION; DIAGNOSIS; CA15-3; CA125;
D O I
10.3233/CBM-160322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Breast cancer is a common gynecological malignant tumor and currently its clinical diagnosis mainly depends on methods of iconography and measurement of serum level. OBJECTIVE: To analyze correlation between serum index levels and prognosis of patients with breast cancer in one week and six months after operation, and to establish support vector machine (SVM) model to evaluate its effectiveness. METHODS: One hundred sixty eight patients diagnosed with breast cancer at Affiliated Cancer Hospital of Zhengzhou University were collected, 46 of which did palindromia while other 122 didn't six months after operation. Serum CA153, CA125 and CEA levels of different periods in two groups were analyzed from their differences. Through receiver operating characteristic (ROC) curve analysis, their diagnostic threshold values were calculated, at the same time, SVM model was built. RESULTS: There was a significant difference between serum index levels of recurrence group and non-recurrence group in one week and six months after operation (P < 0.05); SVM model was established with an accuracy of 96.67% (29/30), a sensitivity of 90% (9/10) and a specificity of 100% (20/20). CONCLUSIONS: Serum CAl53, CEA and CA125 levels after operation have certain instructional significance for prognosis of breast cancer patients, and the established SVM model has high clinical application value.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 33 条
  • [1] Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome
    Abbott, Daniel E.
    Brouquet, Antoine
    Mittendorf, Elizabeth A.
    Andreou, Andreas
    Meric-Bernstam, Funda
    Valero, Vicente
    Green, Marjorie C.
    Kuerer, Henry M.
    Curley, Steven A.
    Abdalla, Eddie K.
    Hunt, Kelly K.
    Vauthey, Jean-Nicolas
    [J]. SURGERY, 2012, 151 (05) : 710 - 716
  • [2] [Anonymous], CANC RES S
  • [3] Belekar V., 2015, COMB CHEM HIGH T SCR, P42
  • [4] Cao Rui, 2012, Cancer Biology Medicine, V9, P57, DOI 10.3969/j.issn.2095-3941.2012.01.011
  • [5] Chen Yan, 2011, Zhonghua Zhong Liu Za Zhi, V33, P842
  • [6] Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3
    Di Gioia, Dorit
    Blankenburg, Irene
    Nagel, Dorothea
    Heinemann, Volker
    Stieber, Petra
    [J]. CLINICA CHIMICA ACTA, 2016, 461 : 1 - 7
  • [7] The Diagnostic Value of 18F-FDG PET/CT in Association with Serum Tumor Marker Assays in Breast Cancer Recurrence and Metastasis
    Dong, Ying
    Hou, Haifeng
    Wang, Chunyan
    Li, Jing
    Yao, Qiong
    Amer, Said
    Tian, Mei
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [8] Dreiseitl S, 2001, J BIOMED INFORM, V34, P28, DOI 10.1006/jbin.2001.10004
  • [9] Fersching DMI, 2012, ANTICANCER RES, V32, P2047
  • [10] Wavelet time-frequency analysis and least squares support vector machines for the identification of voice disorders
    Fonseca, Everthon Silva
    Guido, Rodrigo Capobianco
    Scalassara, Paulo Rogerio
    Maciel, Carlos Dias
    Pereira, Jose Carlos
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2007, 37 (04) : 571 - 578